Literature DB >> 24846474

Vitamin supplementation in the treatment of schizophrenia.

Hannah E Brown1, Joshua L Roffman.   

Abstract

This article reviews the current literature addressing the treatment of schizophrenia with vitamin supplementation. It describes the important roles that vitamins play in normal metabolism, and reviews the evidence pertaining to vitamin deficiency and supplementation in patients with schizophrenia. There is mounting evidence suggesting that vitamin supplementation, in particular with folic acid, vitamin B12 and vitamin D, may be important in treatment within certain subgroups of patients. There is a need for larger randomized controlled trials, and further studies examining the incidence of schizophrenia in countries with poor prenatal care and malnutrition, as well as in countries that have adopted mandatory folic acid fortification of grain products, are recommended.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846474      PMCID: PMC4083629          DOI: 10.1007/s40263-014-0172-4

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  45 in total

1.  Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.

Authors:  Jonathan Rabinowitz; Stephen Z Levine; George Garibaldi; Dragana Bugarski-Kirola; Carmen Galani Berardo; Shitij Kapur
Journal:  Schizophr Res       Date:  2012-02-06       Impact factor: 4.939

2.  Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study.

Authors:  John J McGrath; Darryl W Eyles; Carsten B Pedersen; Cameron Anderson; Pauline Ko; Thomas H Burne; Bent Norgaard-Pedersen; David M Hougaard; Preben B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2010-09

3.  Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.

Authors:  Joseph Levine; Ziva Stahl; Ben-Ami Sela; Vladimir Ruderman; Oleg Shumaico; Ivgeny Babushkin; Yamima Osher; Yuly Bersudsky; R H Belmaker
Journal:  Biol Psychiatry       Date:  2006-01-17       Impact factor: 13.382

4.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

5.  A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population.

Authors:  Akiah Ottesen Berg; Ingrid Melle; Peter A Torjesen; Lars Lien; Edvard Hauff; Ole A Andreassen
Journal:  J Clin Psychiatry       Date:  2010-04-06       Impact factor: 4.384

6.  Co-occurrence of neurodevelopmental genes in etiopathogenesis of autism and schizophrenia.

Authors:  S Hossein Fatemi
Journal:  Schizophr Res       Date:  2010-02-13       Impact factor: 4.939

7.  Folate supplementation in schizophrenia: a possible role for MTHFR genotype.

Authors:  Michele Hill; Kelsey Shannahan; Sarah Jasinski; Eric A Macklin; Lisa Raeke; Joshua L Roffman; Donald C Goff
Journal:  Schizophr Res       Date:  2011-02-21       Impact factor: 4.939

8.  Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia.

Authors:  Meena Arvindakshan; Madhav Ghate; Prabhakar K Ranjekar; Denise R Evans; Sahebarao P Mahadik
Journal:  Schizophr Res       Date:  2003-08-01       Impact factor: 4.939

9.  Enhancement of recovery from psychiatric illness by methylfolate.

Authors:  P S Godfrey; B K Toone; M W Carney; T G Flynn; T Bottiglieri; M Laundy; I Chanarin; E H Reynolds
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

10.  A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals.

Authors:  Joshua L Roffman; Adam Z Nitenson; Yigal Agam; Marlisa Isom; Jesse S Friedman; Kara A Dyckman; David G Brohawn; Jordan W Smoller; Donald C Goff; Dara S Manoach
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

View more
  8 in total

1.  Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.

Authors:  Kenji Sakuma; Shinji Matsunaga; Ikuo Nomura; Makoto Okuya; Taro Kishi; Nakao Iwata
Journal:  Psychopharmacology (Berl)       Date:  2018-05-22       Impact factor: 4.530

Review 2.  Nutritional Factors Affecting Mental Health.

Authors:  So Young Lim; Eun Jin Kim; Arang Kim; Hee Jae Lee; Hyun Jin Choi; Soo Jin Yang
Journal:  Clin Nutr Res       Date:  2016-07-26

3.  Vitamin D Deficiency in Adult Patients with Schizophreniform and Autism Spectrum Syndromes: A One-Year Cohort Study at a German Tertiary Care Hospital.

Authors:  Dominique Endres; Rick Dersch; Oliver Stich; Armin Buchwald; Evgeniy Perlov; Bernd Feige; Simon Maier; Andreas Riedel; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2016-10-06       Impact factor: 4.157

Review 4.  From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism.

Authors:  Rolando I Castillo; Leonel E Rojo; Marcela Henriquez-Henriquez; Hernán Silva; Alejandro Maturana; María J Villar; Manuel Fuentes; Pablo A Gaspar
Journal:  Front Neurosci       Date:  2016-11-08       Impact factor: 4.677

Review 5.  Nutritional therapy can reduce the burden of depression management in low income countries: A review.

Authors:  Moses B Ekong; Clementina F Iniodu
Journal:  IBRO Neurosci Rep       Date:  2021-06-26

Review 6.  The Advent of Nutrigenomics: A Narrative Review with an Emphasis on Psychological Disorders.

Authors:  Meghna Birla; Chanchal Choudhary; Garima Singh; Salvi Gupta; Pratyusha Vavilala
Journal:  Prev Nutr Food Sci       Date:  2022-06-30

Review 7.  Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment.

Authors:  Pronab Ganguly; Abdrabo Soliman; Ahmed A Moustafa
Journal:  Front Public Health       Date:  2018-06-07

8.  Overdispersed gene expression in schizophrenia.

Authors:  Guangzao Huang; Daniel Osorio; Jinting Guan; Guoli Ji; James J Cai
Journal:  NPJ Schizophr       Date:  2020-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.